Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy
Clinical trial NCT00386087 · COMPLETED
Trial details
- NCT number
- NCT00386087
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.